Pantothenate Utilization by Plasmodium as a Target for Antimalarial Chemotherapy
In the absence of an effective vaccine against malaria suitable for widespread deployment, the control of this lethal infectious disease relies heavily on antimalarial chemotherapies. The most virulent of the parasites that cause malaria (Plasmodium falciparum) has, however, developed resistance to all antimalarial agents in clinical use, and there is a desperate need for new antimalarial agents that target previously unexploited parasite processes. P. falciparum requires an extracellular...[Show more]
|Collections||ANU Research Publications|
|Source:||Infectious Disorders - Drug Targets|
|01_Spry_Pantothenate_Utilization_by__2010.pdf||2.27 MB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.